Compare FirstEnergy Corp. (FE) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs Medpace Holdings Inc — how do they compare? FirstEnergy Corp. trades at $49.12 (market cap $28.13B), while Medpace Holdings Inc trades at $535.54 (market cap $15.11B). The key difference: FirstEnergy Corp. is the larger of the two by market cap, and FirstEnergy Corp. pays a 3.82% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| FE | MEDP | |
|---|---|---|
Market Cap | $28.13B | $15.11B |
Sector | Utilities | Technology |
52-Week High | $51.91 | $620.59 |
52-Week Low | $40.30 | $308.88 |
Enterprise Value | $56.14B | $14.58B |
Dividend Yield | 3.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $49.22, up 1.63% with a bullish technical signal. The stock shows consistent revenue growth, reaching $15.09B in 2025, and maintains a net income margin of 6.86%. Analyst consensus is a Buy with a $52.00 price target, supported by strong cash flow from operations of $3.70B. Recent news highlights growth from data center demand and a $36B investment plan.
Outlook remains positive due to strategic investments and rising energy demand, but risks include high debt levels and regulatory pressures. The stock offers steady growth potential with a dividend yield, though investors should monitor execution of capital expenditures and interest rate impacts on financing costs.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
